Evidence map›Paper›PMID 33168755›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.

Rohini Datta, Rohan Roy Chowdhury, Kavyashree Manjunath, Luke Elizabeth Hanna, Raghavan Varadarajan

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Rohini DattaMolecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0003-2693-1922
Rohan Roy ChowdhuryMolecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.ORCID 0000-0003-3586-571X
Kavyashree ManjunathTechnologies for the Advancement of Science, Institute for Stem Cell Science and Regenerative Medicine, Bangalore 560065, India.ORCID 0000-0002-1838-5362
Luke Elizabeth HannaDepartment of HIV/AIDS, National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai 600031, India.
Raghavan VaradarajanMolecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India; varadar@iisc.ac.in.
Indian Institute of Science Bangalore · INIndian Council of Medical Research · INInstitute for Stem Cell Biology and Regenerative Medicine · INJawaharlal Nehru Centre for Advanced Scientific Research · IN

Funding

HIV-1 envelope structure, stability and dynamics probed by saturation mutagenesisR01AI118366 · NIAID · INDIAN INSTITUTE OF SCIENCE · PI VARADARAJAN, RAGHAVAN · 2015 to 2019
$607k
NIAID NIH HHS R01 AI118366
6 · The paper itself

Abstract

Identification of specific epitopes targeted by neutralizing antibodies is essential to advance epitope-based vaccine design strategies. We report a facile methodology for rapid epitope mapping of neutralizing antibodies (NAbs) against HIV-1 Envelope (Env) at single-residue resolution, using Cys labeling, viral neutralization assays, and deep sequencing. This was achieved by the generation of a library of Cys mutations in Env glycoprotein on the viral surface, covalent labeling of the Cys residues using a Cys-reactive label that masks epitope residues, followed by infection of the labeled mutant virions in mammalian cells in the presence of NAbs. Env gene sequencing from NAb-resistant viruses was used to accurately delineate epitopes for the NAbs VRC01, PGT128, and PGT151. These agreed well with corresponding experimentally determined structural epitopes previously inferred from NAb:Env structures. HIV-1 infection is associated with complex and polyclonal antibody responses, typically composed of multiple antibody specificities. Deconvoluting the epitope specificities in a polyclonal response is a challenging task. We therefore extended our methodology to map multiple specificities of epitopes targeted in polyclonal sera, elicited in immunized animals as well as in an HIV-1-infected elite neutralizer capable of neutralizing tier 3 pseudoviruses with high titers. The method can be readily extended to other viruses for which convenient reverse genetics or lentiviral surface display systems are available.

Indexed as

AIDS VaccinesAntibodies, NeutralizingAntibody FormationAntibody SpecificityCell LineCysteineenv Gene Products, Human Immunodeficiency VirusEpitope MappingEpitopesHEK293 CellsHigh-Throughput Nucleotide SequencingHIV-1HIV AntibodiesHIV InfectionsHIV SeropositivityHumansAIDS VaccinesAntibodies, NeutralizingCysteineenv Gene Products, Human Immunodeficiency VirusEpitopesHIV Antibodiescysteine scanning mutagenesisepitope mappingHIV-1 Envneutralizing antibodiespolyclonal sera

Identifiers

PMID33168755
PMCPMC7703538
OpenAlexW3101923994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.